Magellan Aerospace: Strong Buy As Margins Expand And Valuation Gap Persists

Magellan Aerospace is described as still undervalued despite being up 168% since initial coverage, supported by 11% revenue growth and an expansion in adjusted EBITDA margin to 11.2%. The company’s EBITDA is projected to grow 16.5% annually, free cash flow could rise 45% annually, and a net cash position is expected by 2027. The note remains constructive on MAL:CA given improved operating leverage and a favorable longer-term outlook.

Analysis

The market is still likely underestimating the duration of Magellan’s mix shift. Higher-margin engine and casting content tends to compound because it is not just volume-sensitive; it also improves OEM qualification depth, which makes share gains stickier than a simple cyclical upswing. If EBITDA and FCF are inflecting at the stated pace, the equity is increasingly a balance-sheet rerating story rather than a pure earnings multiple expansion story.

The second-order winner is likely any supplier or customer chain that can ride Magellan’s throughput without needing equivalent capital intensity. That can pressure smaller, more levered peers that are forced to chase aerospace demand with working-capital drag and delayed free cash flow conversion. The hidden loser is not necessarily a direct competitor by product line, but any adjacent industrial name priced on near-term revenue growth rather than cash generation, because Magellan is showing that margin quality is the scarcer asset.

The main risk is timing mismatch: aerospace programs can look linear until a single customer schedule slips, engine shop demand normalizes, or input costs reaccelerate. Over the next 3-6 months, the stock can keep rerating on margin credibility; over 12-24 months, the key test is whether cash conversion translates into sustained net-cash optionality rather than just de-levering optics. The consensus may be missing that the stock is no longer just cheap on current earnings — it is cheap on normalized balance-sheet power if management executes through 2026.

This looks like an underappreciated compounding story, not a one-quarter beat. The move is not obviously overdone if free cash flow is truly accelerating, but the cleaner entry is on any drawdown tied to broader industrial de-risking rather than on strength after the rerating already happened.

Key Decisions for Investors

• Maintain/add to long MAL.TO on pullbacks over the next 2-6 weeks; target a 12-month rerating if FCF inflects as expected. Risk/reward improves materially if the market continues to price it as a cyclical industrial rather than a cash-generating aerospace compounder.
• Pair trade: long MAL.TO / short a lower-quality aerospace or industrial supplier with weaker FCF conversion and higher leverage. Hold 3-9 months; the spread should widen if Magellan continues to de-risk its balance sheet while peers remain capital hungry.
• Buy medium-dated call spreads on MAL.TO for a 6-12 month horizon to express upside from continued margin expansion while limiting multiple-compression risk. Best use if implied volatility remains cheap relative to fundamentals.
• Watch for any guide-up or contract award confirmation as a catalyst to add, but reduce exposure if margins stall for two consecutive quarters; the thesis is cash conversion, not just revenue growth.